| Index | — | P/E | 22.92 | EPS (ttm) | 5.23 | Insider Own | 43.92% | Shs Outstand | 32.03M | Perf Week | 3.90% |
| Market Cap | 3.84B | Forward P/E | 23.47 | EPS next Y | 5.11 | Insider Trans | -0.01% | Shs Float | 18.05M | Perf Month | 5.19% |
| Enterprise Value | 3.79B | PEG | 2.02 | EPS next Q | 1.81 | Short Float | 10.82% | Perf Quarter | -6.76% | ||
| Income | 167.00M | P/S | 2.56 | EPS this Y | -5.43% | Short Ratio | 8.41 | Perf Half Y | 33.58% | ||
| Sales | 1.50B | P/B | 3.52 | EPS next Y | 4.60% | ROA | 11.26% | Short Interest | 1.95M | Perf YTD | 41.29% |
| Book/sh | 34.07 | P/C | 18.19 | EPS next 5Y | 11.32% | ROE | 19.15% | 52W High | 129.29 -7.29% | Perf Year | 34.06% |
| Cash/sh | 6.59 | P/FCF | 15.48 | EPS past 3/5Y | 11.50% 34.06% | ROIC | 15.82% | 52W Low | 77.21 55.24% | Perf 3Y | -5.06% |
| Dividend Est. | 3.20 (2.67%) | EV/EBITDA | 12.84 | Sales past 3/5Y | 11.06% 22.54% | Gross Margin | 63.82% | Volatility | 2.04% 2.36% | Perf 5Y | 53.96% |
| Dividend TTM | 3.20 (2.67%) | EV/Sales | 2.52 | EPS Y/Y TTM | -15.37% | Oper. Margin | 17.26% | ATR (14) | 3.07 | Perf 10Y | 281.11% |
| Dividend Ex-Date | Sep 15, 2026 | Quick Ratio | 2.00 | Sales Y/Y TTM | 2.88% | Profit Margin | 11.17% | RSI (14) | 63.51 | Recom | 2.52 |
| Dividend Gr. 3/5Y | 16.96% 57.52% | Current Ratio | 3.31 | EPS Q/Q | -4.04% | SMA20 | 4.64% | Beta | 1.06 | Target Price | 136.50 |
| Payout | 61.15% | Debt/Eq | 0.15 | Sales Q/Q | 2.10% | SMA50 | 4.62% | Rel Volume | 0.91 | Prev Close | 116.37 |
| Employees | 662 | LT Debt/Eq | 0.10 | Earnings | Nov 04 | SMA200 | 14.51% | Avg Volume | 223.79K | Price | 119.86 |
| IPO Date | Feb 04, 1988 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -2.06% 0.00% | Net Debt/EBITDA | -0.18 | Volume | 203,346 | Change | 3.00% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-14-26 | Reiterated | Berenberg Bank | $130 | |
| Aug-10-26 | Reiterated | Goldman Sachs | Buy → Neutral | $129 |
| Aug-10-26 | Downgrade | TD Cowen | Buy → Hold | |
| Jul-30-26 | Reiterated | Canaccord Genuity | Buy | $141 → $151 |
| Jul-28-26 | Reiterated | Jefferies | Buy | $112 → $145 |
| Jul-23-26 | Reiterated | Canaccord Genuity | Buy | $141 |
| Jan-14-26 | Reiterated | Jefferies | Buy | $125 → $112 |
| Nov-21-25 | Initiated | Berenberg | Buy | $103 |
| Nov-21-25 | Downgrade | BWS Financial | Buy → Neutral | |
| Oct-28-25 | Reiterated | Jefferies | Buy | $125 |
Inter Parfums, Inc., through its various subsidiaries, is engaged in the global development, marketing, and distribution of perfumes and related scented merchandise. The company's operations are divided into two main geographical segments: those based in Europe and those in the United States. It offers a wide array of fragrances and cosmetic products under license for many renowned luxury and fashion brands, including Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lily Aldridge, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, babe, Dunhill, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, French Connection, and Ungaro, as well as under its proprietary names, Intimate and Aziza. These products are sold through diverse channels such as major department stores, specialized retail outlets, travel retail locations (duty-free), beauty product chains, domestic and international wholesale partners, and an expanding e-commerce platform. Founded in 1982, the enterprise was initially known as Jean Philippe Fragrances, Inc. before changing its corporate identity to Inter Parfums, Inc. in July 1999. Its corporate headquarters are situated in New York, New York.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,502 | 1,489 | 1,452 | 1,318 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 544 | 541 | 525 | 479 | — | — | — | — | — | |
| Gross Profit | 959 | 947 | 927 | 839 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 700 | 677 | 649 | 588 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 4 | 0 | — | — | — | — | — | |
| Operating Income | 260 | 270 | 275 | 251 | — | — | — | — | — | |
| Interest Expense | 4 | 7 | 8 | 11 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 14 | 8 | 1 | 9 | — | — | — | — | — | |
| Net Income Before Taxes | 268 | 271 | 268 | 250 | — | — | — | — | — | |
| Income Taxes | 62 | 63 | 65 | 62 | — | — | — | — | — | |
| Consolidated Net Income | 167 | 168 | 164 | 153 | — | — | — | — | — | |
| Net Income From Continuing Operations | 206 | 208 | 203 | 188 | — | — | — | — | — | |
| Net Income | 167 | 168 | 164 | 153 | — | — | — | — | — | |
| EPS (Recurring) | 5.23 | 5.25 | 5.13 | 4.77 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 5.23 | 5.25 | 5.13 | 4.77 | — | — | — | — | — | |
| EPS (Diluted) | 5.23 | 5.24 | 5.12 | 4.75 | — | — | — | — | — | |
| EBITDA | 295 | 304 | 305 | 278 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 22.92 | 16.19 | 25.69 | 30.32 | — | — | — | — | — | |
| Price To Sales Ratio | 2.55 | 1.82 | 2.90 | 3.50 | — | — | — | — | — | |
| Gross Margin | 63.85 | 63.60 | 63.84 | 63.66 | — | — | — | — | — | |
| Operating Margin | 17.31 | 18.13 | 18.94 | 19.04 | — | — | — | — | — | |
| Net Margin | 11.12 | 11.28 | 11.29 | 11.61 | — | — | — | — | — | |
| Shares Outstanding | 32 | 32 | 32 | 32 | — | — | — | — | — | |
| Market Capitalization | 3,836 | 2,715 | 4,208 | 4,608 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Gabai-Pinsky Veronique | Director | Aug 27 '26 | Option Exercise | 97.84 | 1,200 | 117,408 | 900 | Aug 27 |
| Gabai-Pinsky Veronique | Director | Aug 27 '26 | Sale | 116.86 | 900 | 105,173 | 0 | Aug 27 |
| MADAR JEAN | CEO | Apr 02 '26 | Sale | 91.02 | 20,000 | 1,820,360 | 7,066,341 | Apr 03 |
| HEILBRONN FRANCOIS | Director | Jan 23 '26 | Option Exercise | 62.18 | 1,875 | 116,588 | 30,063 | Jan 26 |
| Harrison Gilbert | Director | Jan 22 '26 | Option Exercise | 62.18 | 1,875 | 116,588 | 3,050 | Jan 23 |
| BENSOUSSAN TORRES ROBERT | Director | Jan 22 '26 | Option Exercise | 62.18 | 1,875 | 116,588 | 12,500 | Jan 23 |
| Bouillonnec Herve | Global Chief Commercial Office | Dec 15 '25 | Option Exercise | 73.09 | 1,800 | 131,562 | 1,500 | Dec 17 |
| MADAR JEAN | CEO | Dec 15 '25 | Option Exercise | 73.09 | 30,000 | 2,192,700 | 7,086,341 | Dec 15 |
| BENACIN PHILIPPE | President Interparfums SA | Dec 11 '25 | Option Exercise | 73.09 | 30,000 | 2,192,700 | 6,871,064 | Dec 12 |
| BENACIN PHILIPPE | President Interparfums SA | Dec 11 '25 | Sale | 83.24 | 25,000 | 2,080,963 | 6,846,064 | Dec 12 |
| Harrison Gilbert | Director | Jun 23 '25 | Sale | 133.96 | 400 | 53,584 | 1,550 | Jun 25 |
| SANTI PHILIPPE | Exec VP Interparfums SA | Jun 11 '25 | Option Exercise | 73.09 | 1,000 | 73,090 | 1,000 | Jun 11 |
| SANTI PHILIPPE | Exec VP Interparfums SA | Jun 11 '25 | Sale | 139.28 | 1,000 | 139,276 | 0 | Jun 11 |
| SANTI PHILIPPE | Exec VP Interparfums SA | Jun 10 '25 | Option Exercise | 73.09 | 1,000 | 73,090 | 1,000 | Jun 11 |
| SANTI PHILIPPE | Exec VP Interparfums SA | Jun 10 '25 | Sale | 139.23 | 1,000 | 139,233 | 0 | Jun 11 |